Focus Partners Advisor Solutions’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.92M Sell
5,467
-4,811
-47% -$1.72M 0.02% 361
2025
Q4
$3.36M Buy
10,278
+3,044
+42% +$966K 0.04% 213
2025
Q3
$2.08M Sell
7,234
-1,669
-19% -$484K 0.02% 330
2025
Q2
$2.49M Buy
8,903
+152
+2% +$43.1K 0.03% 244
2025
Q1
$2.73M Buy
8,751
+253
+3% +$74.7K 0.04% 206
2024
Q4
$2.22M Buy
8,498
+2,264
+36% +$672K 0.04% 212
2024
Q3
$2.01M Buy
6,234
+182
+3% +$59.5K 0.04% 198
2024
Q2
$1.89M Sell
6,052
-109
-2% -$32K 0.05% 175
2024
Q1
$1.75M Buy
6,161
+4,267
+225% +$1.25M 0.05% 173
2023
Q4
$546K Sell
1,894
-4,147
-69% -$1.13M 0.03% 242
2023
Q3
$1.62M Buy
6,041
+1,732
+40% +$432K 0.08% 121
2023
Q2
$957K Sell
4,309
-239
-5% -$55.5K 0.05% 143
2023
Q1
$1.1M Sell
4,548
-431
-9% -$106K 0.07% 116
2022
Q4
$1.31M Sell
4,979
-1,606
-24% -$431K 0.1% 109
2022
Q3
$1.48M Buy
6,585
+1,285
+24% +$311K 0.09% 113
2022
Q2
$1.29M Sell
5,300
-99
-2% -$24.3K 0.11% 94
2022
Q1
$1.3M Buy
+5,399
New +$1.24M 0.13% 99

Other funds holding AMGN

Focus Partners Advisor Solutions's AMGN Position: Q1 2026 in Review

Focus Partners Advisor Solutions reduced its Amgen (AMGN) stake by 47% in Q1 2026, selling an estimated $1.72M and leaving 5,467 shares worth $1.92M. The position accounts for 0.02% of the portfolio, ranked #361.

Focus Partners Advisor Solutions first reported a position in AMGN in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.36M in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Focus Partners Advisor Solutions held 5,467 shares of Amgen worth $1.92M as of Q1 2026.
  • Focus Partners Advisor Solutions sold 4,811 Amgen shares in Q1 2026, an estimated $1.72M.
  • Amgen made up 0.02% of Focus Partners Advisor Solutions's portfolio in Q1 2026, its #361 holding.
  • Focus Partners Advisor Solutions first reported a position in Amgen in Q1 2022 and has held it in 17 quarters since.
  • Focus Partners Advisor Solutions's Amgen position peaked at $3.36M in Q4 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q1 2026, filed 13 May 2026.